Literature DB >> 17609393

Validation of a microsphere-based immunoassay for detection of anti-West Nile virus and anti-St. Louis encephalitis virus immunoglobulin m antibodies.

Alison J Johnson1, Ronald C Cheshier, Giorgio Cosentino, Heather P Masri, Valerie Mock, Rebecca Oesterle, Robert S Lanciotti, Denise A Martin, Amanda J Panella, Olga Kosoy, Brad J Biggerstaff.   

Abstract

A microsphere-based immunoassay (MIA) was previously developed that is capable of determining the presence of anti-West Nile (WN) virus or anti-St. Louis encephalitis (SLE) virus immunoglobulin M (IgM) antibodies in human serum or cerebrospinal fluid. The original data set on which the classification rules were based comprised 491 serum specimens obtained from the serum bank at the Division of Vector-Borne Infectious Diseases of the Centers for Disease Control and Prevention (DVBID). The classification rules were used to provide a result and to determine whether confirmatory testing was necessary for a given sample. A validation study was coordinated between the DVBID and five state health laboratories to determine (i) the reproducibility of the test between different laboratories, (ii) the correlation between the IgM-enzyme-linked immunosorbent assay (MAC-ELISA) and the MIA, and (iii) whether the initial nonspecific parameters could be refined to reduce the volume of confirmatory testing. Laboratorians were trained in the method, and reagents and data analysis software developed at the DVBID were shipped to each validating laboratory. Validating laboratories performed tests on approximately 200 samples obtained from their individual states, the collections of which comprised approximately equal numbers of WN virus-positive and -negative samples, as determined by MAC-ELISA. In addition, 377 samples submitted to the DVBID for arbovirus testing were analyzed using the MIA and MAC-ELISA at the DVBID only. For the specimens tested at both the state and the DVBID laboratories, a correlation of results indicated that the technology is readily transferable between laboratories. The detection of IgM antibodies to WN virus was more consistent than detection of IgM antibodies to SLE virus. Some changes were made to the analysis software that resulted in an improved accuracy of diagnosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17609393      PMCID: PMC2043310          DOI: 10.1128/CVI.00115-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  21 in total

1.  Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay.

Authors:  A J Johnson; D A Martin; N Karabatsos; J T Roehrig
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

2.  Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.

Authors:  Thomas P Monath; Farshad Guirakhoo; Richard Nichols; Sutee Yoksan; Robert Schrader; Chris Murphy; Paul Blum; Stephen Woodward; Karen McCarthy; Danell Mathis; Casey Johnson; Philip Bedford
Journal:  J Infect Dis       Date:  2003-10-03       Impact factor: 5.226

3.  West Nile virus activity--United States, 2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-07-15       Impact factor: 17.586

Review 4.  Multiplexed testing in the autoimmunity laboratory.

Authors:  José M González-Buitrago
Journal:  Clin Chem Lab Med       Date:  2006       Impact factor: 3.694

5.  Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins.

Authors:  Tim Waterboer; Peter Sehr; Kristina M Michael; Silvia Franceschi; John D Nieland; Thomas O Joos; Markus F Templin; Michael Pawlita
Journal:  Clin Chem       Date:  2005-08-11       Impact factor: 8.327

6.  Use of immunoglobulin m cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States.

Authors:  Denise A Martin; Brad J Biggerstaff; Becky Allen; Alison J Johnson; Robert S Lanciotti; John T Roehrig
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

7.  Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections.

Authors:  D A Martin; D A Muth; T Brown; A J Johnson; N Karabatsos; J T Roehrig
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

8.  West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays.

Authors:  B S Davis; G J Chang; B Cropp; J T Roehrig; D A Martin; C J Mitchell; R Bowen; M L Bunning
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

9.  Detection of human anti-flavivirus antibodies with a west nile virus recombinant antigen microsphere immunoassay.

Authors:  Susan J Wong; Valerie L Demarest; Rebekah H Boyle; Tian Wang; Michel Ledizet; Kalipada Kar; Laura D Kramer; Erol Fikrig; Raymond A Koski
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

10.  Use of sentinel laboratories by clinicians to evaluate potential bioterrorism and emerging infections.

Authors:  Brian C Pien; J Royden Saah; Sara E Miller; Christopher W Woods
Journal:  Clin Infect Dis       Date:  2006-03-31       Impact factor: 9.079

View more
  14 in total

1.  Evaluation of widely used diagnostic tests to detect West Nile virus infections in horses previously infected with St. Louis encephalitis virus or dengue virus type 2.

Authors:  Jeremy P Ledermann; Maria A Lorono-Pino; Christine Ellis; Kali D Saxton-Shaw; Bradley J Blitvich; Barry J Beaty; Richard A Bowen; Ann M Powers
Journal:  Clin Vaccine Immunol       Date:  2011-02-23

2.  Fatal transplant-associated west nile virus encephalitis and public health investigation-california, 2010.

Authors:  Ingrid B Rabe; Brian S Schwartz; Eileen C Farnon; S Andrew Josephson; Allison B Webber; John Paul Roberts; Angelo M de Mattos; Brian J Gallay; Sean van Slyck; Sharon L Messenger; Cynthia J Yen; Evan M Bloch; Clifton P Drew; Marc Fischer; Carol A Glaser
Journal:  Transplantation       Date:  2013-09-15       Impact factor: 4.939

Review 3.  Diagnostic Approach for Arboviral Infections in the United States.

Authors:  Anne Piantadosi; Sanjat Kanjilal
Journal:  J Clin Microbiol       Date:  2020-11-18       Impact factor: 5.948

4.  St. Louis encephalitis virus possibly transmitted through blood transfusion-Arizona, 2015.

Authors:  Heather Venkat; Laura Adams; Rebecca Sunenshine; Elisabeth Krow-Lucal; Craig Levy; Tammy Kafenbaum; Tammy Sylvester; Kirk Smith; John Townsend; Melissa Dosmann; Hany Kamel; Roberto Patron; Matthew Kuehnert; Pallavi Annambhotla; Sridhar V Basavaraju; Ingrid B Rabe
Journal:  Transfusion       Date:  2017-09-14       Impact factor: 3.157

5.  Development of a fluorescent-microsphere immunoassay for detection of antibodies specific to equine arteritis virus and comparison with the virus neutralization test.

Authors:  Yun Young Go; Susan J Wong; Adam J Branscum; Valerie L Demarest; Kathleen M Shuck; Mary L Vickers; Jianqiang Zhang; William H McCollum; Peter J Timoney; Udeni B R Balasuriya
Journal:  Clin Vaccine Immunol       Date:  2007-11-21

Review 6.  Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic features.

Authors:  Drew J Winston; Holenarasipur R Vikram; Ingrid B Rabe; Gundeep Dhillon; David Mulligan; Johnny C Hong; Ronald W Busuttil; Marek J Nowicki; Thomas Mone; Rachel Civen; Selam A Tecle; Kavita K Trivedi; Susan N Hocevar
Journal:  Transplantation       Date:  2014-05-15       Impact factor: 4.939

7.  A multi-center ring trial of allergen analysis using fluorescent multiplex array technology.

Authors:  Eva M King; Stephanie Filep; Bryan Smith; Thomas Platts-Mills; Robert G Hamilton; Detlef Schmechel; Joanne E Sordillo; Donald Milton; Ronald van Ree; Esmeralda J M Krop; Dick J J Heederik; Nervana Metwali; Peter S Thorne; Darryl C Zeldin; Michelle L Sever; Agustin Calatroni; Samuel J Arbes; Herman E Mitchell; Martin D Chapman
Journal:  J Immunol Methods       Date:  2012-10-22       Impact factor: 2.303

8.  A Multiplex Microsphere-Based Immunoassay Increases the Sensitivity of SIV-Specific Antibody Detection in Serum Samples and Mucosal Specimens Collected from Rhesus Macaques Infected with SIVmac239.

Authors:  Rebecca L R Powell; Ian Ouellette; Ross W Lindsay; Christopher L Parks; C Richter King; Adrian B McDermott; Gavin Morrow
Journal:  Biores Open Access       Date:  2013-06

Review 9.  Recent progress in West Nile virus diagnosis and vaccination.

Authors:  Marina De Filette; Sebastian Ulbert; Mike Diamond; Niek N Sanders
Journal:  Vet Res       Date:  2012-03-01       Impact factor: 3.683

10.  Effect of serum heat-inactivation and dilution on detection of anti-WNV antibodies in mice by West Nile virus E-protein microsphere immunoassay.

Authors:  Madhuri Namekar; Mukesh Kumar; Maile O'Connell; Vivek R Nerurkar
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.